Q32 Bio Inc. (QTTB) Income Statement

2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue0.00-6.65M6.65M33.97M2.70M1.67M5.32M0.00
Cost of Revenue487000.00578000.002.60M9.54M0.000.000.00684214.00
Gross Profit-487000.00-7.23M4.05M24.43M2.70M1.67M5.32M-684214.00
R&D Expenses48.14M31.73M35.81M29.93M100.39M89.40M47.95M21.38M
SG&A Expenses17.47M9.88M10.06M6.76M23.67M15.89M16.01M7.60M
Operating Expenses65.61M41.60M45.88M36.69M124.06M105.29M63.96M28.97M
Interest Income3.90M0.000.000.001.57M6.03M4.35M542635.00
Interest Expense300000.000.000.000.000.000.000.000.00
Depreciation & Amortization487000.00499000.002.60M9.54M8.90M6.32M1.29M684214.00
EBITDA-45.30M-47.76M-38.85M-86.22M-121.36M-103.63M-58.64M-29.31M
EBITDA RatioN/A7.18-5.84-2.54-44.91-62.2-11.02N/A
Operating Income-66.10M-48.26M-39.23M-36.69M-130.26M-109.94M-59.93M-29.66M
Operating Income RatioN/A7.26-5.9-1.08-48.21-65.99-11.26N/A
Income Before Tax-46.09M-53.42M-42.75M-37.02M-128.69M-103.92M-55.58M-29.99M
Income Before Tax RatioN/A8.03-6.43-1.09-47.63-62.37-10.44N/A
Income Tax Expense21000.00318000.0062000.00547000.000.000.000.00-4.00
Net Income-47.73M-53.74M-42.81M-37.56M-128.69M-103.92M-55.58M-29.99M
EPS-5.12-16.7-13.42-12.23-50.46-44.41-35.04-14.42
EPS Diluted-6.58-16.7-13.42-12.23-50.46-44.41-35.04-14.42

View Income statements

CAR CRGY IRS OPY DTM FGBI FFIN SPCE WTRG PCB ARWR SAR